Mental Health

Mental Health

At Boehringer Ingelheim, we aspire to provide mental health treatment approaches that places an individual’s specific needs at the center. Our efforts go beyond pharmacologic interventions because we recognize that the needs of people living with mental health conditions are complex and highly individualized. We believe the future of care for people with mental illnesses will often involve a combination of treatment modalities that could include pharmacotherapies, behavioral therapies, psychosocial interventions, community support, and prescription digital therapeutics, to achieve more integrated and tailored solutions that enable better outcomes.

Together, we’re championing every mind for generations.

Latest Articles on Mental Health

It's time to look Beyond Stable

Learn about cognitive impairment, an often overlooked and highly disruptive symptom domain of schizophrenia

Decorative image of two women laughing and spending time together

Mental Disorders

Mental health: a $1 trillion burden demanding policy action

Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.

Illustration of woman and man on a puzzle

Mental Disorders

Mental Health and the Value of Connection

Yammie and Jurgen share their story of friendship, and how much they value connection as people living with mental health conditions.

Schizophrenia is characterized by three symptom domains and affects ~1% of global population. First and mostly known are the positive symptoms like hallucinations and delusions, secondly are negative symptoms like reduced emotion and lack of motivation and the third symptom domain is cognitive symptoms like a poor memory or disorganized thinking. While there are already many drugs for treating positive symptoms, there is a significant unmet medical need for effective treatments for negative and cognitive symptoms.